Clinical significance of lymphatic and blood vessel invasion in oral tongue squamous cell carcinomas

详细信息	查看全文 | 推荐本文 |

• 作者：Chieko Michikawa^a ; ^b ; ^{c-michikawa.mfs@tmd.ac.jp} ; Narikazu Uzawa^a ; ^{n-uzawa.mfs@tmd.ac.jp} ; Kou Kayamori^b ; ^c ; ^{kayamori.mpa@tmd.ac.jp} ; Itaru Sonoda^a ; ^{italu_mfs@yahoo.co.jp} ; Yoshio Ohyama^a ; ^{yohyama1219@gmail.com} ; Norihiko Okada^b ; ^{nokd.opth@tmd.ac.jp} ; Akira Yamaguchi^d ; ^{akira.mpa@tmd.ac.jp} ; Teruo Amagasa^a ; ^{amagasa.mfs@tmd.ac.jp}
• 关键词：Lymphatic vessel invasion ; Blood vessel invasion ; Oral tongue ; Squamous cell carcinoma ; D2-40 ; Elastica van Gieson stain ; Lymph node ; Metastasis ; Prognosis
• 刊名：Oral Oncology
• 出版年：2012
• 期刊代码：213_13688375
• 类别：med
• 出版时间：April, 2012
• 卷：48
• 期：4
• 页码：320-324
• 文件大小：781 K

摘要

| Figures/TablesFigures/Tables | ReferencesReferences

Summary

Although vascular invasion (VI) is recognized as an important predictor of lymph node metastasis and a significant prognostic factor in head and neck squamous cell carcinoma (HNSCC), there is currently no common definition for the pathological evaluation of VI status. We reviewed the medical records of 63 consecutive resected primary oral tongue SCCs (OTSCCs) without preoperative treatment between June 1999 and April 2008, and evaluated VI status by investigating lymphatic vessel invasion (LVI) and blood vessel invasion (BVI) by using immunohistochemistry (IHC) with monoclonal antibody D2-40 (D2-40) and Elastica van Gieson (EVG) staining, respectively. Subsequently, we analyzed their correlations with cervical lymph node metastasis and prognosis. LVI was found in 16 of the 63 tumors (25.4%) and BVI was in 32 tumors (50.8%). Univariate analysis revealed that the presence of LVI is statistically correlated with lymph node metastasis. Moreover, multivariate logistic regression analysis revealed that LVI is an independent risk factor of nodal metastasis (odds ratio = 4.262, 95%confidence interval = 1.262-14.397, p = 0.020). In contrast, Kaplan-Meier survival analysis revealed that patients with BVI had a significantly shorter disease-free survival (DFS) and overall survival (OS) rates than those without BVI (68.6%versus 90.3%, p = 0.028 and 68.6%versus 93.5%, p = 0.013, respectively). The present study clearly demonstrated that LVI at primary OTSCC had significant correlation with lymph node metastasis, and that BVI was significantly associated with recurrence and poor prognosis. Evaluation of VI status, as LVI and BVI status separately, using IHC with D2-40 and EVG staining may be useful in predicting lymph node metastasis and poor prognosis in OTSCCs.